MedTrace Logo

New Serological Markers for Eosinophilic Esophagitis

NCT01624129 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2025-01-09

No results posted yet for this study

Summary

The purpose of the study is to investigate if serological parameters such as "extracellular Serum-Tryptase (ST)" and "eosinophilic cationic protein (ECP)" are useful for the diagnosis and surveillance of the eosinophilic esophagitis (EE).

Conditions

  • Eosinophilic Esophagitis

Interventions

DRUG

Fluticasone

Guideline-based treatment with fluticasone 0,5 ml (1-0-1), step-up or step-down after 3 months based on the histopathological findings

Sponsors & Collaborators

  • Technical University of Munich

    lead OTHER

Principal Investigators

  • Monther Bajbouj, MD · Technical University of Munich, 2nd Medical Department

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2012-10-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01624129 on ClinicalTrials.gov